nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ACSL4—Synthesis of very long-chain fatty acyl-CoAs—ELOVL4—age related macular degeneration	0.237	0.237	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty Acyl-CoA Biosynthesis—ELOVL4—age related macular degeneration	0.197	0.197	CbGpPWpGaD
Rosiglitazone—ACSL4—Triglyceride Biosynthesis—ELOVL4—age related macular degeneration	0.108	0.108	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty Acid Beta Oxidation—LIPC—age related macular degeneration	0.0509	0.0509	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—ELOVL4—age related macular degeneration	0.0325	0.0325	CbGpPWpGaD
Rosiglitazone—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.0131	0.0131	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.013	0.013	CbGpPWpGaD
Rosiglitazone—CYP2C19—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0125	0.0125	CbGpPWpGaD
Rosiglitazone—CYP2D6—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0115	0.0115	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—ELOVL4—age related macular degeneration	0.00998	0.00998	CbGpPWpGaD
Rosiglitazone—CYP1A2—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.00972	0.00972	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—CRP—age related macular degeneration	0.00911	0.00911	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.00859	0.00859	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.00819	0.00819	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00778	0.00778	CbGpPWpGaD
Rosiglitazone—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.00777	0.00777	CbGpPWpGaD
Rosiglitazone—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.0075	0.0075	CbGpPWpGaD
Rosiglitazone—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.00692	0.00692	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—NMNAT1—age related macular degeneration	0.0066	0.0066	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ELOVL4—age related macular degeneration	0.00577	0.00577	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00534	0.00534	CbGpPWpGaD
Rosiglitazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.00522	0.00522	CbGpPWpGaD
Rosiglitazone—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00516	0.00516	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00516	0.00516	CbGpPWpGaD
Rosiglitazone—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00498	0.00498	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00472	0.00472	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—CD36—age related macular degeneration	0.00471	0.00471	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SLC16A8—age related macular degeneration	0.00465	0.00465	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—CST3—age related macular degeneration	0.00401	0.00401	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00398	0.00398	CbGpPWpGaD
Rosiglitazone—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.00397	0.00397	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00381	0.00381	CbGpPWpGaD
Rosiglitazone—CYP2C19—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00367	0.00367	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—CD36—age related macular degeneration	0.00354	0.00354	CbGpPWpGaD
Rosiglitazone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.00351	0.00351	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00347	0.00347	CbGpPWpGaD
Rosiglitazone—CYP2D6—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00337	0.00337	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.0031	0.0031	CbGpPWpGaD
Rosiglitazone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.0031	0.0031	CbGpPWpGaD
Rosiglitazone—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00286	0.00286	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—SQSTM1—age related macular degeneration	0.00279	0.00279	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00278	0.00278	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00273	0.00273	CbGpPWpGaD
Rosiglitazone—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0027	0.0027	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00269	0.00269	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00267	0.00267	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00266	0.00266	CbGpPWpGaD
Rosiglitazone—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.00264	0.00264	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.0026	0.0026	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0024	0.0024	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0024	0.0024	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—LIPC—age related macular degeneration	0.00238	0.00238	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—CETP—age related macular degeneration	0.0023	0.0023	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00224	0.00224	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.0022	0.0022	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00216	0.00216	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—F13B—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00206	0.00206	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NMNAT1—age related macular degeneration	0.00203	0.00203	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—ERCC6—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00196	0.00196	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00178	0.00178	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ELOVL4—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RAD51B—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NMNAT1—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00158	0.00158	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00158	0.00158	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SLC16A8—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ELOVL4—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—CD36—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NMNAT1—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—APOE—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ELOVL4—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SLC16A8—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CD36—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.000979	0.000979	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000951	0.000951	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC16A8—age related macular degeneration	0.000945	0.000945	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.000932	0.000932	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—KDR—age related macular degeneration	0.00092	0.00092	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.000916	0.000916	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000912	0.000912	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NMNAT1—age related macular degeneration	0.000911	0.000911	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000839	0.000839	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.000818	0.000818	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.000801	0.000801	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ELOVL4—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000752	0.000752	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000749	0.000749	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000746	0.000746	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000742	0.000742	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000738	0.000738	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—LIPC—age related macular degeneration	0.00073	0.00073	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000716	0.000716	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.000715	0.000715	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000712	0.000712	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CETP—age related macular degeneration	0.000705	0.000705	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000677	0.000677	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000666	0.000666	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000662	0.000662	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000661	0.000661	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000658	0.000658	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000646	0.000646	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000642	0.000642	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000639	0.000639	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000637	0.000637	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000604	0.000604	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000588	0.000588	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000583	0.000583	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000576	0.000576	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—LIPC—age related macular degeneration	0.000575	0.000575	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000557	0.000557	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CETP—age related macular degeneration	0.000555	0.000555	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.00053	0.00053	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000525	0.000525	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—LIPC—age related macular degeneration	0.000512	0.000512	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—VEGFA—age related macular degeneration	0.000507	0.000507	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CETP—age related macular degeneration	0.000494	0.000494	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—LIPC—age related macular degeneration	0.000484	0.000484	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—CD36—age related macular degeneration	0.00047	0.00047	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CETP—age related macular degeneration	0.000467	0.000467	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000449	0.000449	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000434	0.000434	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00043	0.00043	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000428	0.000428	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CD36—age related macular degeneration	0.000424	0.000424	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00038	0.00038	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000377	0.000377	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—APOE—age related macular degeneration	0.000374	0.000374	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000339	0.000339	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CD36—age related macular degeneration	0.000334	0.000334	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LIPC—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000319	0.000319	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CETP—age related macular degeneration	0.000317	0.000317	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000309	0.000309	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000299	0.000299	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CD36—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000295	0.000295	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000285	0.000285	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD36—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000271	0.000271	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000264	0.000264	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000262	0.000262	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—age related macular degeneration	0.000262	0.000262	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CETP—age related macular degeneration	0.00026	0.00026	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.00023	0.00023	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000224	0.000224	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000192	0.000192	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—age related macular degeneration	0.000191	0.000191	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000171	0.000171	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000169	0.000169	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—age related macular degeneration	0.000168	0.000168	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000157	0.000157	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000156	0.000156	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000151	0.000151	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000139	0.000139	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000133	0.000133	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000118	0.000118	CbGpPWpGaD
